相关实验视频

Updated: May 30, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

GRP78:在结直肠癌的发病和治疗方面,一个新的有前途的候选者

Wang Song¹, Neda Rahimian², Aysa Hasanzade Bashkandi³

¹Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong'an Road, Shanghai, 200032, China.

European journal of pharmacology

|January 27, 2025

概括

葡萄糖调节蛋白78 (GRP78) 在结直肠癌 (CRC) 的发展和进展中至关重要. 针对GRP78提供了一个有希望的策略,以改善CRC治疗结果和克服化疗抵抗.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生化学

背景情况:

结肠直肠癌 (CRC) 是一个严重的全球健康负担,具有复杂的发病因子.
葡萄糖调节蛋白78 (GRP78),是内细胞网膜 (ER) 应激和未折叠蛋白质反应 (UPR) 的关键调节者,与CRC有关.
了解GRP78的作用对于开发有效的CRC疗法至关重要.

研究的目的:

在CRC中审查GRP78的表达特征.
阐明GRP78在CRC病变发生中的作用,包括其对细胞机制的调制.
探索在CRC中准GRP78的治疗潜力.

主要方法:

在CRC中GRP78表达的文献综述.
分析GRP78与关键信号通路 (Akt,Wnt,PERK,VEGF,Kras) 的分子相互作用.
检查GRP78在自,糖解和免疫调节中的参与.

主要成果:

在CRC中,GRP78的表达被改变,与预后潜力相关联.
GRP78影响CRC细胞的增殖,迁移,入侵和生存.
GRP78与瘤进展和化学抵抗至关重要的多个信号通路相互作用.
在CRC中,GRP78在自,糖解和免疫逃避中发挥作用.
天然化合物 (黄素,EGCG,) 调节了GRP78.8.
GRP78调解了对5-FU和氧化等化疗药物的耐药性.

结论:

GRP78是结直肠癌发病过程中的核心分子参与者.
准GRP78为CRC提供了一个有前途的治疗策略.
调节GRP78可能会提高治疗效率,并克服CRC中的化学抵抗.

关键词:

陪伴者 (Chaperones) 是指一个陪伴者.结肠癌是什么意思结肠癌是什么意思细胞内膜网膜应激压力是什么在HSP70中,HSP70是药物治疗药物治疗不折叠的蛋白质反应反应

更多相关视频

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Published on: July 18, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...